Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Form 8.3 APAX GLOBAL ALPHA LTD

17 Sep 2025 14:57

RNS Number : 7528Z
Barclays PLC
17 September 2025
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

APAX GLOBAL ALPHA LTD

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

16 Sep 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

Ordinary NPV

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

6,155,332

1.28%

63,993

0.01%

(2)

Cash-settled derivatives:

 

 

 

 

 

 

 

 

58,506

0.01%

6,150,789

1.28%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

6,213,838

1.29%

6,214,782

1.29%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

Ordinary NPV

Purchase

897,300

1.6440 GBP

Ordinary NPV

Purchase

127,100

1.6421 GBP

Ordinary NPV

Purchase

15,381

1.6441 GBP

Ordinary NPV

Purchase

5,379

1.6460 GBP

Ordinary NPV

Purchase

3,777

1.6466 GBP

Ordinary NPV

Purchase

1,113

1.6420 GBP

Ordinary NPV

Sale

474,510

1.6440 GBP

Ordinary NPV

Sale

242,270

1.6434 GBP

Ordinary NPV

Sale

31,077

1.6420 GBP

Ordinary NPV

Sale

11,675

1.6406 GBP

Ordinary NPV

Sale

5,039

1.6460 GBP

Ordinary NPV

Sale

4,914

1.6421 GBP

Ordinary NPV

Sale

3,073

1.6436 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

Ordinary NPV

SWAP

Decreasing Short

49,281

1.6439 GBP

Ordinary NPV

SWAP

Decreasing Short

11,815

1.6442 GBP

Ordinary NPV

SWAP

Increasing Short

184,168

1.6440 GBP

Ordinary NPV

SWAP

Increasing Short

60,653

1.6442 GBP

Ordinary NPV

CFD

Decreasing Short

11,279

1.6439 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercise

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 Sep 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPKOBPNBKDDCD
Date   Source Headline
26th Mar 20201:12 pmRNSStatement regarding COVID-19
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn
19th Mar 202012:02 pmRNSPrice Monitoring Extension
17th Mar 20204:00 pmRNSDirector/PDMR Shareholding
17th Mar 20204:00 pmRNSDirector/PDMR Shareholding
13th Mar 202012:07 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 202012:07 pmRNSSecond Price Monitoring Extn
12th Mar 202012:02 pmRNSPrice Monitoring Extension
11th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSNotice of Results
5th Mar 20202:17 pmRNSPurchase of Ordinary Shares under IM Agreement
5th Mar 20207:00 amRNSNotice of Investor Day
3rd Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSUpdated Key Information Document
3rd Mar 20207:00 amRNSNotice of AGM
3rd Mar 20207:00 amRNS2019 Annual Dividend
3rd Mar 20207:00 amRNS2019 Final Results
3rd Mar 20207:00 amRNS2019 Annual Report and Accounts
14th Feb 20207:00 amRNSDirector Change - Appointment
4th Feb 20207:00 amRNSApax Funds' Valuations as at 31 December 2019
15th Jan 20203:31 pmRNSPDMR Shareholding
15th Jan 20203:30 pmRNSPDMR Shareholding
26th Nov 20194:35 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSNotice of Annual Results
6th Nov 20197:00 amRNSQuarterly Results for 30 September 2019
16th Oct 20197:00 amRNSApax Funds' Valuations as at 30 September 2019
27th Sep 20194:40 pmRNSSecond Price Monitoring Extn
27th Sep 20194:35 pmRNSPrice Monitoring Extension
16th Sep 201910:37 amRNSNotice of Quarterly Results - September 2019
20th Aug 20199:17 amRNSPDMR Dealing - Share Transfers
14th Aug 20197:00 amRNS2019 Interim Dividend
14th Aug 20197:00 amRNS2019 Interim Results Highlights
14th Aug 20197:00 amRNS2019 Interim Report and Accounts
1st Aug 20197:00 amRNSApax Digital Fund Valuation as at 30 June 2019
30th Jul 20197:00 amRNSApax Funds' Valuations as at 30 June 2019
15th Jul 201910:59 amRNSProposed commitment to the Apax X Fund
22nd May 20197:00 amRNSAGA Investor Day
17th May 20194:30 pmRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSNotice of Interim Results - June 2019
8th May 201912:28 pmRNSResult of AGM Replacement
8th May 20197:00 amRNSQuarterly Results for 31 March 2019
7th May 20196:30 pmRNSResult of AGM
5th Apr 20195:32 pmRNSApax Funds' Valuations as at 31 March 2019
19th Mar 20192:39 pmRNSNotice of Investor Day
18th Mar 20199:59 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.